116252-38-1

Basic information

• Product Name: 4-methoxybenzyl-(Z)-3-(chloromethyl)-7-(2-(methoxyimino)-2-(2-(tritylamino)thiazol-4-yl)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
• Synonyms: 4-methoxybenzyl-(Z)-3-(chloromethyl)-7-(2-(methoxyimino)-2-(2-(tritylamino)thiazol-4-yl)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
• CAS NO: 116252-38-1
• Molecular Weight: 794.352
• Mol File: 116252-38-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-methoxybenzyl-(Z)-3-(chloromethyl)-7-(2-(methoxyimino)-2-(2-(tritylamino)thiazol-4-yl)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-methoxybenzyl-(Z)-3-(chloromethyl)-7-(2-(methoxyimino)-2-(2-(tritylamino)thiazol-4-yl)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate(116252-38-1)
• EPA Substance Registry System: 4-methoxybenzyl-(Z)-3-(chloromethyl)-7-(2-(methoxyimino)-2-(2-(tritylamino)thiazol-4-yl)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate(116252-38-1)

Safety Data

• Hazardous Substances Data: 116252-38-1(Hazardous Substances Data)

Upstream product

• 106773-36-8 4-methoxybenzyl-7-amino-3-chloromethyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride 
• 64485-90-1 2-(2-aminothiazol-4-yl)-2-(methoxy)iminoacetic acid 

Downstream Products

• 127108-57-0 4-methoxybenzyl (6R,7R)7β-{2-{2-aminotrityl-1,3-thiazol-4-yl}-2-[(Z)-methoxyimino]-acetylamino}-3-(iodomethyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate 
• 134481-45-1 (6R,7R)-7-<2-(2-amino-thiazol-4-yl)-2-(Z)-(methoxyimino)acetamido>-3-<1-(methylamino)pyridinium-4-thiomethyl>ceph-3-em-4-carboxylate 
• 157463-09-7 (6R,7R)-3-((E)-4-Hydroxy-but-2-enyl)-7-{2-[(Z)-methoxyimino]-2-[2-(trityl-amino)-thiazol-4-yl]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid 4-methoxy-benzyl ester 

Relevant articles and documents

NOVEL CEPHALOSPORINS

The present invention relates to novel compounds of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts and compositions, metabolites and prodrugs thereof.

Structure-activity relationships within a series of C(7)-substitutedoxyiminocephalosporins containing the C(3)-methylaminopyridiniumthiomethyl substituent synthesis and biological properties of BRL 57342 and some close analogues

(6R,7R)-7-[2-(2-Amino-4-thiazolyl)-2-[(Z)-[(S)-carboxy(3,4 -dihydroxyphenyl)methyl]oxy-imino]acetamido]-3-(1-methylaminopyridinium-4 -thiomethyl)ceph-3-em-4-carboxylate sodium salt (BRL 57342, If) combines excellent in vitro antibacterial potency against Gram-positive and Gram-negative bacteria, including P. aeruginosa and Acinetobacter spp., with excellent stability to extended spectrum β-lactamases. This potency is reflected in in vivo efficacy studies.